Posted by Michael Wonder on 29 Jan 2020
Understanding the rewards of successful drug development — thinking inside the box
30 January 2020 - Risks and rewards change during the life cycle of a drug. In the innovation period, drug companies invest in developing new products but cannot sell them.
Newly approved drugs initially have exclusivity and enter the monopoly period, which is followed by the competitive period, when branded drugs compete with generics.
The influence of policies on financial incentives in each period is described.
